BMV:XBI Holdings Information

BMV:XBI is an equity ETF with a total of 128 individual holdings. The top holdings are Moderna stock at 2.71%, Exelixis at 2.53%, United Therapeutics at 2.53%, Neurocrine Biosciences at 2.52%, and Regeneron Pharmaceuticals at 2.52%.

Total Holdings

128

Top 10 Percentage

25.11%

Asset Class

Equity

ETF Category

Health Care

Assets

4.70B

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	MRNA	Moderna, Inc.	2.71%	4,267,295
2	EXEL	Exelixis, Inc.	2.53%	2,858,270
3	UTHR	United Therapeutics Corporation	2.53%	428,282
4	NBIX	Neurocrine Biosciences, Inc.	2.52%	953,715
5	REGN	Regeneron Pharmaceuticals, Inc.	2.52%	228,356
6	HALO	Halozyme Therapeutics, Inc.	2.50%	2,199,009
7	INSM	Insmed Incorporated	2.50%	1,208,569
8	ALNY	Alnylam Pharmaceuticals, Inc.	2.48%	396,640
9	VRTX	Vertex Pharmaceuticals Incorporated	2.44%	261,743
10	AMGN	Amgen Inc.	2.39%	405,767
11	GILD	Gilead Sciences, Inc.	2.38%	1,083,467
12	INCY	Incyte Corporation	2.36%	1,719,936
13	BMRN	BioMarin Pharmaceutical Inc.	2.36%	2,071,695
14	ABBV	AbbVie Inc.	2.32%	618,384
15	BBIO	BridgeBio Pharma, Inc.	2.29%	2,424,097
16	BIIB	Biogen Inc.	2.28%	889,934
17	EXAS	Exact Sciences Corporation	2.27%	2,127,532
18	NTRA	Natera, Inc.	2.14%	710,157
19	BPMC	Blueprint Medicines Corporation	1.97%	756,469
20	MDGL	Madrigal Pharmaceuticals, Inc.	1.89%	302,273
21	TGTX	TG Therapeutics, Inc.	1.77%	2,318,621
22	ROIV	Roivant Sciences Ltd.	1.66%	7,278,811
23	CYTK	Cytokinetics, Incorporated	1.60%	2,087,926
24	IONS	Ionis Pharmaceuticals, Inc.	1.51%	1,783,399
25	CRSP	CRISPR Therapeutics AG	1.49%	1,408,570

As of Jul 15, 2025

Showing 25 of 128

Subscribe to see the full list